Aprea Therapeutics, Inc. (APRE) vs KALA BIO, Inc. (KALA)

Aprea Therapeutics, Inc. and KALA BIO, Inc. are both Biotechnology companies. Aprea Therapeutics, Inc. and KALA BIO, Inc. are of similar size ($10.7M and $9.8M). KALA BIO, Inc. grew revenue faster over the last twelve months: −50.5% against −81.0%. Across the 13 metrics below, Aprea Therapeutics, Inc. leads on 8 and KALA BIO, Inc. on 5.

Valuation

Metric APRE KALA Biotechnology median
P/E n/m n/m 7.88
P/S 144.15 0.01 11.47
P/B 1.07 0.00 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.00 n/m 0.74
EV/Sales (0.18) 7.52 10.73
Earnings yield (140.26%) (6,658.33%) (28.84%)
Free cash flow yield (29.60%) (56,050.65%) (23.03%)

Profitability

Metric APRE KALA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (47.44%) (345.32%) (57.72%)
Return on assets (41.30%) (43.23%) (49.22%)
Return on invested capital 0.00% (722.69%) 0.00%

Growth

Metric APRE KALA Biotechnology median
Revenue growth (TTM) (80.99%) (50.54%) 5.64%
EPS growth (last fiscal year) 17.87% 67.39% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APRE KALA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.55 6.88 4.73
Net debt to EBITDA 1.11 0.19 0.96

Dividend

Metric APRE KALA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric APRE KALA Biotechnology median
Market cap 9.82m 10.73m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack